Novo Nordisk : NVO

All Novo Nordisk Articles

171 Articles

David Moadel | Mar 17, 2026 at 12:27 PM EDT

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Eli Lilly (NYSE:LLY | LLY Price Prediction) stock is down 5% in Tuesday afternoon trading, with shares falling to $937…

Joel South | Mar 10, 2026 at 10:23 AM EDT

Wall Street Pulls Back on Novo Nordisk and Jefferies While Talkspace Heads for Exit

Four names are drawing analyst attention this week, with TD Cowen stepping back from Novo Nordisk A/S (NYSE:NVO | NVO…

Lee Jackson | Mar 10, 2026 at 8:06 AM EDT

Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe’s, Qualcomm, Rivian, Strategy and More

Pre-Market Stock Futures: Futures are trading lower as many across Wall Street breathed a semi-sigh of relief yesterday after oil…

Lee Jackson | Mar 3, 2026 at 8:00 AM EST

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Block, CrowdStrike, Fortinet, MongoDB, Mosaic, Palo Alto Networks, Unity Software, and More

Pre-Market Stock Futures: Futures are down big as oil shoots higher on Tuesday. After a big early morning sell-off on…

Lee Jackson | Mar 2, 2026 at 7:56 AM EST

Here Are Monday’s Top Wall Street Analyst Research Calls: AppLovin, Blue Owl Capital, CrowdStrike, Dutch Bros., Jet Blue, Novo Nordisk, PayPal, Twilio, and More

Pre-Market Stock Futures: The futures are trading lower after a dreadful Friday and week, one that could be laying the…

David Beren | Feb 25, 2026 at 7:08 AM EST

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

After finding itself some unwanted attention this week, Novo Nordisk (NYSE:NVO | NVO Price Prediction) has dropped 22% in the…

David Beren | Feb 16, 2026 at 2:00 PM EST

Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

Editor’s note: A prior version of this article stated Eli Lilly and Nvidia had funded a supercomputer, when the commitment…

John Seetoo | Feb 11, 2026 at 7:15 AM EST

GLP-1 Lawsuits Are the Black Swan Risk Investors Aren’t Watching

One of the biggest trends in the fight against obesity has been the explosion in popularity of GLP-1 medications. Created…

Austin Smith | Feb 9, 2026 at 11:59 AM EST

HIMs 22% Collapse Looks Like A ‘Buy The Dip’ Moment

Shares of Hims & Hers Health (NYSE:HIMS) plunged 22% at market open on Monday, February 9. The telehealth company pulled…

Douglas A. McIntyre | Feb 9, 2026 at 10:39 AM EST

Hims & Hers Falls Apart, Again

Hims & Hers Health (NASDAQ: HIMS) has had among the worst runs of any public company over the last year.…

Rich Duprey | Feb 4, 2026 at 2:39 PM EST

Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank

The rivalry in the GLP-1 market between pharmaceutical leaders Eli Lilly (NYSE:LLY | LLY Price Prediction) and Novo Nordisk (NYSE:NVO)…

Austin Smith | Jan 23, 2026 at 10:36 AM EST

VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion

The VanEck Pharmaceutical ETF (NYSEARCA:PPH) has surged 26% over the past year, driven almost entirely by the weight-loss drug revolution.…

Joel South | Jan 21, 2026 at 8:20 AM EST

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)

Novo Nordisk sees the obesity drug market expanding to $100 billion by 2030. With promising new treatments in the pipeline,…

Ian Cooper | Dec 24, 2025 at 9:47 AM EST

Stock Market Live December 24, 2025: S&P 500 (SPY) at Record Highs

With the holidays upon us, markets aren’t moving much. Instead, many are taking time off to enjoy the holidays and…

Rich Duprey | Dec 23, 2025 at 1:23 PM EST

Novo Nordisk Strikes First With Oral Wegovy — But Can It Outrun Lilly’s Looming Pill?

Yesterday, the Food and Drug Administration (FDA) approved Novo Nordisk‘s (NYSE:NVO | NVO Price Prediction) Wegovy weight-loss pill, the first…

1 2 3 4 5 … 12

Novo Nordisk : NVO

All Novo Nordisk Articles

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Wall Street Pulls Back on Novo Nordisk and Jefferies While Talkspace Heads for Exit

Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe’s, Qualcomm, Rivian, Strategy and More

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Block, CrowdStrike, Fortinet, MongoDB, Mosaic, Palo Alto Networks, Unity Software, and More

Here Are Monday’s Top Wall Street Analyst Research Calls: AppLovin, Blue Owl Capital, CrowdStrike, Dutch Bros., Jet Blue, Novo Nordisk, PayPal, Twilio, and More

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

GLP-1 Lawsuits Are the Black Swan Risk Investors Aren’t Watching

HIMs 22% Collapse Looks Like A ‘Buy The Dip’ Moment

Hims & Hers Falls Apart, Again

Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank

VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)

Stock Market Live December 24, 2025: S&P 500 (SPY) at Record Highs

Novo Nordisk Strikes First With Oral Wegovy — But Can It Outrun Lilly’s Looming Pill?

What It Takes to Retire to Minnesota’s Lake Country at 62 on $900,000

Congress Has Six Years to Save Social Security: Here’s What’s at Stake

Collect $2,000 a Month in Rent and Never Meet a Tenant. These 3 ETFs Handle the Hard Part

What It Takes to Retire to Minnesota's Lake Country at 62 on $900,000

Congress Has Six Years to Save Social Security: Here's What's at Stake

What It Takes to Retire to Minnesota’s Lake Country at 62 on $900,000

Congress Has Six Years to Save Social Security: Here’s What’s at Stake

Novo Nordisk : NVO

All Novo Nordisk Articles

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares

Wall Street Pulls Back on Novo Nordisk and Jefferies While Talkspace Heads for Exit

Here Are Tuesday’s Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims & Hers, Intuit, Lowe’s, Qualcomm, Rivian, Strategy and More

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Block, CrowdStrike, Fortinet, MongoDB, Mosaic, Palo Alto Networks, Unity Software, and More

Here Are Monday’s Top Wall Street Analyst Research Calls: AppLovin, Blue Owl Capital, CrowdStrike, Dutch Bros., Jet Blue, Novo Nordisk, PayPal, Twilio, and More

Novo Nordisk Cuts Wegovy Prices in Half While Its Stock Sits Near a 52-Week Low

Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery

GLP-1 Lawsuits Are the Black Swan Risk Investors Aren’t Watching

HIMs 22% Collapse Looks Like A ‘Buy The Dip’ Moment

Hims & Hers Falls Apart, Again

Eli Lilly Is Dominating the GLP-1 Wars as Novo Nordisk Sales Tank

VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion

Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Jan 2026)

Stock Market Live December 24, 2025: S&P 500 (SPY) at Record Highs

Novo Nordisk Strikes First With Oral Wegovy — But Can It Outrun Lilly’s Looming Pill?

What It Takes to Retire to Minnesota’s Lake Country at 62 on $900,000

Congress Has Six Years to Save Social Security: Here’s What’s at Stake

Collect $2,000 a Month in Rent and Never Meet a Tenant. These 3 ETFs Handle the Hard Part

Featured Reads

What It Takes to Retire to Minnesota's Lake Country at 62 on $900,000

Congress Has Six Years to Save Social Security: Here's What's at Stake